SYNTHETIC BIOLOGY MARKET ANALYSIS

Synthetic Biology Market, By Product (Oligonucleotides , Enzymes , Synthetic Cells , Chassis Organism , and Others), By Technology (Genome Engineering , PCR Technology , Bioprocessing Technology , NGS Technology , Bioinformatics , Nanotechnology , and Others), By End User (Pharmaceutical Companies , Biotechnology Companies , CMO & CRO , and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

On February 28, 2024, bit.bio, a company that codes human cells for innovative therapies, and Ginkgo Bioworks, which is developing the leading platform for cell programming and biosecurity, introduced bit.bio as an inaugural partner of the Ginkgo Technology Network. The Network is a pioneering network of cutting-edge technology partners dedicated to cooperating with Ginkgo Bioworks to deliver new, integrated capabilities that enable success in customer R&D programs.
In July 2023, Sumitomo Chemical Co., Ltd., one of Japan's leading chemical companies, and Ginkgo Bioworks announced a new program to develop functional chemicals using synthetic biology, expanding on the companies' existing biomanufacturing collaboration.
In May 2023, Octarine Bio, a synthetic biology company developing new sustainable bio-based ingredients, and Ginkgo Bioworks announced a multi-stage collaboration focused on compounds in the tryptophan pathway, with the goal of engineering a strain to produce violacein and its derivatives, a naturally occurring bis-indole pigment with potent bioactive properties such as anti-microbial, anti-oxidant, and UV protection.
In January 2023, Twist Bioscience Corporation, a company that helps customers succeed by providing high-quality synthetic DNA on its silicon platform, announced the shipment of the first products from its second manufacturing site, the Factory of the Future, in Oregon, U.S.